Europe Blood and Blood Components Market 2020 By Regional Trend & Growth Forecast To 2024

Europe Blood and Blood Components Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

Rising number of trauma cases, surgical procedures and road accidents will fuel Europe blood and blood components market size owing to increased need for blood transfusions to address loss of blood from the injuries.

Moreover, there is a rising demand for cosmetic surgeries that will boost the demand for blood components, thereby driving the industry growth. The blood components segment of had dominated the Europe blood and blood components industry share in 2017 and is estimated to grow to $3.9 billion by 2024.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/3398

Increasing rates of conditions like bleeding disorders, anemia along with procedures like aesthetic surgeries, infections and chemotherapy will contribute towards the Europe blood and blood components market size considerably. Blood components that are of higher costs and have a specific use are expected to impact positively on the revenue size over the forecast time period.

The cancer treatment application segment is estimated to grow at a considerably faster rate due to the growing prevalence of several cancer forms. Blood components help compensate for lower blood cell count, bolstering the demand for blood components. Steady inclination towards unhealthy eating lifestyle in the European region will escalate cancer risks and further stimulate the regional growth.

The trauma and surgery application segment had held more than 40% of Europe blood and blood components market share in 2017. Surge in the number of injuries that lead to a surgery will boost the demand for blood and blood components in the forthcoming years. Most trauma cases need massive amounts of blood transfusion.

Rise in the number of surgical procedures in ambulatory surgical centers owing to shorter procedural time and focused care will offer significant potential for growth in the segment. Ambulatory surgical centers accounted for over $1.5 billion of the total Europe blood and blood components industry size in the year 2017.

Rise in the disposable income at hand has increased the demand for surgeries, along with the presence of favorable health insurance policies that are gradually including ambulatory care within their scope of coverage.

Russia blood and blood component market is expected to experience a considerable rate of growth over the projected time period. Surge in the number of blood donations will play a major role in boosting the industry growth.

Additionally, the growing geriatric population base coupled with several initiatives taken by the government to encourage blood donations by the Russian population will add to the increased supply of blood from all blood group categories. Russia blood and blood component market share is poised to record momentous gains in the future.

Notable associations like NHS Blood and Transplant (NHSBT), Northern Island Blood Transfusion Service, IFRC and Welsh Blood Services operate in Europe. The associations have been introducing and implementing strategic initiatives that include awareness initiatives, expansion strategies, and collaborations that have been enhancing the market awareness regarding various products available and proliferating Europe blood and blood components industry trends. 

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/europe-blood-and-blood-components-market

Partial Chapter of the Table of Content 

Chapter 4. Europe Blood and Blood Components Market, By Product

4.1. Key segment trends

4.2. Whole blood

4.2.1.1.Market size, by country, 2013 – 2024 (USD Million)

4.3. Blood components

4.3.1.1.Market size, by country, 2013 – 2024 (USD Million)

4.3.1.2.Market size, by country, 2013 – 2024 (Units)

4.3.2. Red blood cells

4.3.2.1. Market size, by country, 2013 – 2024 (USD Million)

4.3.2.2.Market size, by country, 2013 – 2024 (Units)

4.3.3. Platelets

4.3.3.1. Market size, by country, 2013 – 2024 (USD Million)

4.3.3.2.Market size, by country, 2013 – 2024 (Units)

4.3.4. Plasma

4.3.4.1. Market size, by country, 2013 – 2024 (USD Million)

4.3.4.2.Market size, by country, 2013 – 2024 (Units)

4.3.5. White blood cells

4.3.5.1. Market size, by country, 2013 – 2024 (USD Million)

4.3.5.2.Market size, by country, 2013 – 2024 (Units)

Chapter 5. Europe Blood and Blood Components Market, By Application

5.1. Key segment trends

5.2. Anemia

5.2.1.Market size, by country, 2013 – 2024 (USD Million)

5.3. Trauma & surgery

5.3.1.Market size, by country, 2013 – 2024 (USD Million)

5.4. Cancer treatment

5.4.1.Market size, by country, 2013 – 2024 (USD Million)

5.5. Bleeding disorders

5.5.1.Market size, by country, 2013 – 2024 (USD Million)

5.6. Others

5.6.1.Market size, by country, 2013 – 2024 (USD Million)